House Republicans Seek Top Down Change To FDA’s Warning-Letter Appeals
This article was originally published in The Tan Sheet
Executive SummaryFDA leadership needs to review the agency's enforcement dispute resolution process, according to ranking Republicans on the House Energy and Commerce Committee
You may also be interested in...
The authors of a large cohort study of the uptake of robotic-assisted surgery in Michigan hospitals argue that the rapid adoption of robotic techniques is not supported by existing clinical evidence.